Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression

Sei Morinaga, Robert M. Hoffman, KOHEI MIZUTA et al.|Frontiers in Oncology|2025

Cited by 1